Sodium Bicarbonate Drip for Severe Metabolic Acidosis (pH < 7.20)
For adults with severe metabolic acidosis (pH < 7.20) and moderate-to-severe acute kidney injury, administer sodium bicarbonate 4.2% solution as a continuous infusion targeting arterial pH ≥ 7.30, starting with an initial bolus of 50-100 mEq (50-100 mL of 8.4% solution diluted 1:1 with sterile water) given slowly over several minutes, followed by continuous infusion at 1-3 mL/kg/hour of a 150 mEq/L solution. 1, 2, 3
Primary Indications
Sodium bicarbonate is indicated when:
- Arterial pH < 7.1 with base excess < -10 mEq/L AND documented metabolic acidosis (not respiratory) 1, 2
- Life-threatening sodium channel blocker or tricyclic antidepressant toxicity with QRS prolongation > 120 ms 1, 2
- Life-threatening hyperkalemia as temporizing measure while definitive therapy is initiated 1, 2
- Diabetic ketoacidosis with pH < 6.9 1
Do NOT use sodium bicarbonate for:
- Hypoperfusion-induced lactic acidemia with pH ≥ 7.15 (strong evidence of no benefit and potential harm from multiple RCTs) 1, 4
- Routine cardiac arrest without specific indications 1, 2
- Respiratory acidosis (treat with ventilation, not bicarbonate) 1
Dosing and Preparation
Initial Bolus Dosing
- Adults: 1-2 mEq/kg IV (typically 50-100 mEq or 50-100 mL of 8.4% solution) given slowly over several minutes 1, 2, 3
- Pediatric (≥2 years): 1-2 mEq/kg IV given slowly 1, 2
- Pediatric (<2 years): Use only 4.2% concentration (dilute 8.4% solution 1:1 with sterile water), maximum 8 mEq/kg/day 1, 2
Continuous Infusion Protocol
- Prepare 150 mEq/L solution: Add 150 mEq sodium bicarbonate to 1 liter of appropriate diluent 1, 2
- Infusion rate: 1-3 mL/kg/hour, titrated to maintain arterial pH ≥ 7.30 1, 2
- Target pH: 7.2-7.3 (NOT complete normalization to 7.4) 1, 2, 3
Special Toxicology Dosing
- TCA/sodium channel blocker overdose: Initial bolus 50-150 mEq using hypertonic solution (1000 mEq/L), followed by continuous infusion of 150 mEq/L at 1-3 mL/kg/hour, targeting pH 7.45-7.55 1, 2
Critical Safety Considerations
Absolute Contraindications to Mixing
- Never mix with: Calcium-containing solutions (causes precipitation), norepinephrine, dobutamine, epinephrine, or other catecholamines (causes inactivation) 1, 3
- Flush IV line with normal saline before and after bicarbonate administration 1
Ventilation Requirements
Ensure adequate ventilation BEFORE each dose - bicarbonate generates CO2 that must be eliminated; giving bicarbonate without adequate ventilation causes paradoxical intracellular acidosis and worsens outcomes 1, 2
- Target minute ventilation to achieve PaCO2 30-35 mmHg during bicarbonate therapy 1
Monitoring Requirements
Arterial Blood Gas Monitoring
- Every 2-4 hours during active therapy to assess pH, PaCO2, bicarbonate response 1, 2
- Stop infusion when pH reaches 7.2-7.3 1, 2, 3
Electrolyte Monitoring (Every 2-4 Hours)
- Sodium: Target < 150-155 mEq/L (bicarbonate causes hypernatremia) 1, 2
- Potassium: Monitor closely and replace aggressively - bicarbonate shifts potassium intracellularly, causing severe hypokalemia 1, 2
- Ionized calcium: Monitor with doses > 50-100 mEq; bicarbonate decreases ionized calcium, impairing cardiac contractility 1, 2
Clinical Monitoring
- Hemodynamics: Mean arterial pressure, vasopressor requirements 1
- Fluid balance: Watch for volume overload, especially in oliguric patients 1, 3
- Cardiac rhythm: Continuous ECG monitoring, especially in toxicity cases 1
Stepwise Administration Algorithm
Step 1: Verify indication (pH < 7.1 with metabolic acidosis OR specific toxicology/hyperkalemia indication) 1, 2
Step 2: Ensure adequate ventilation is established or will be immediately established 1, 2
Step 3: Obtain baseline labs: arterial blood gas, complete metabolic panel including ionized calcium 1, 2
Step 4: Administer initial bolus 50-100 mEq (1-2 mEq/kg) slowly over several minutes using 4.2% solution (dilute 8.4% solution 1:1 with sterile water for safety) 1, 2, 3
Step 5: Start continuous infusion of 150 mEq/L solution at 1-3 mL/kg/hour 1, 2
Step 6: Recheck arterial blood gas and electrolytes in 2 hours 1, 2
Step 7: Titrate infusion rate based on pH response, targeting pH 7.2-7.3 1, 2, 3
Step 8: Stop infusion when pH ≥ 7.2-7.3, or if sodium > 150-155 mEq/L, or pH > 7.50-7.55 1, 2
Common Pitfalls and How to Avoid Them
Pitfall 1: Giving Bicarbonate for Lactic Acidosis with pH ≥ 7.15
The BICARICU-2 trial (2025) definitively showed NO mortality benefit in patients with severe metabolic acidemia and acute kidney injury - day 90 mortality was identical (62.1% vs 61.7%) 4. Multiple RCTs show no hemodynamic benefit and potential harm (increased lactate, fluid overload, decreased ionized calcium) 1, 4. Only consider if pH < 7.1 AND after optimizing hemodynamics and ventilation 1.
Pitfall 2: Using Hypertonic 8.4% Solution Without Dilution
Always dilute to 4.2% concentration (1:1 with sterile water) to reduce risk of hyperosmolar complications, hypernatremia, and cerebral injury 1, 2. The 8.4% solution has osmolality of 2000 mOsm/L, which is extremely hypertonic 1.
Pitfall 3: Inadequate Ventilation During Bicarbonate Administration
Each 1 mEq of bicarbonate generates 1 mEq of CO2 that must be eliminated 1. Giving bicarbonate to a patient who cannot increase minute ventilation causes paradoxical intracellular acidosis and worsens outcomes 1, 2. Ensure mechanical ventilation or adequate spontaneous ventilation before each dose 1.
Pitfall 4: Ignoring Potassium Shifts
Bicarbonate causes rapid intracellular potassium shift - monitor potassium every 2-4 hours and replace aggressively to prevent life-threatening hypokalemia 1, 2. This is especially critical in diabetic ketoacidosis where insulin also drives potassium intracellularly 1.
Pitfall 5: Mixing with Catecholamines or Calcium
Bicarbonate inactivates catecholamines and precipitates with calcium 1, 3. Use separate IV lines or flush thoroughly with normal saline before and after bicarbonate 1.
Pitfall 6: Attempting Complete pH Normalization
Target pH 7.2-7.3, NOT 7.4 1, 2, 3. Overshoot alkalosis causes worse outcomes due to decreased oxygen delivery (leftward shift of oxyhemoglobin curve), hypokalemia, hypocalcemia, and paradoxical CNS acidosis 1, 3.
Adverse Effects to Monitor
- Hypernatremia and hyperosmolarity (each 50 mL of 8.4% solution contains 44.6 mEq sodium) 1, 3
- Hypokalemia (intracellular shift) 1, 2
- Hypocalcemia (decreased ionized calcium) 1, 2
- Fluid overload (large sodium and volume load) 1, 3
- Paradoxical intracellular acidosis (if ventilation inadequate) 1, 2
- Metabolic alkalosis (overshoot) 1, 3
- Increased lactate production (paradoxical effect) 1
Duration of Therapy
Continue infusion until:
- Target pH 7.2-7.3 achieved 1, 2, 3
- Underlying cause corrected and adequate circulation restored 1, 5
- Serum sodium approaches 150-155 mEq/L 1, 2
- pH approaches 7.50-7.55 1, 2
- QRS narrowing and hemodynamic stability in toxicity cases 1, 2
Do not exceed 6 mEq/kg total dose - higher doses commonly cause hypernatremia, fluid overload, metabolic alkalosis, and cerebral edema 1.